Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
CPI Card Group Inc. - Common Stock
Cinedigm Corp - Class A Common Stock
Digital Garage Inc
First Trust Indxx Medical Devices ETF
J & J Snack Foods Corp. - Common Stock
SSR Mining Inc. - Common Stock
Sprout Social, Inc - Class A Common Stock
Texas Community Bancshares, Inc. - Common Stock
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zivo Bioscience, Inc. - Common Stock
(OP:
ZIVO
)
6.500
-0.014 (-0.21%)
Delayed Quote
Updated: 3:38 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zivo Bioscience, Inc. - Common Stock
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q2 2024
↗
August 16, 2024
Zivo Bioscience just reported results for the second quarter of 2024.
Via
InvestorPlace
ZIVO Bioscience Secures Commercial-Scale Manufacturing Agreement with Cyanotech Corporation for Zivolife™ Algal Biomass
April 06, 2026
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Provides Special Letter to Shareholders
March 27, 2026
From
ZIVO Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025
From
ZIVO Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry
June 20, 2025
From
ZIVO Bioscience, Inc.
Via
Business Wire
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 06, 2025
From
ZIVO Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025
From
ZIVO Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience to Present at The Microcap Conference 2025
January 22, 2025
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens
August 23, 2024
From
ZIVO Bioscience, Inc.
Via
Business Wire
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08, 2024
From
ZIVO Bioscience, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
